MYOK

MyoKardia, Inc.CIK 1552451 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for MYOK PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for MYOK

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Waynick Denelle J	General Counsel	4	$0	$0	2020-11-17
Fairey William	See Remarks	10	$0	$197.2K	2020-11-17
Bauer Jake	See Remarks	78	$0	$6.56M	2020-11-17
AGARWAL SUNIL	Director	19	$0	$0	2020-11-17
Harris Taylor C.	Chief Financial Officer	19	$0	$247.1K	2020-11-17
GIANAKAKOS ANASTASIOS	President and CEO	195	$132.5K	$13.76M	2020-11-17
McDowell Robert Scott	Senior VP, Drug Discovery	28	$0	$181.4K	2020-11-17
Meeker David P	Director	17	$0	$0	2020-11-17
Popovits Kimberly J	Director	17	$0	$0	2020-11-17
PERRY MARK L	Director	20	$50.0K	$0	2020-11-17
YARNO WENDY L	Director	18	$50.0K	$0	2020-11-17
CRANSTON MARY B	Director	30	$0	$4.25M	2020-11-17
LADD CYNTHIA J	General Counsel	8	$0	$126.6K	2020-02-14
Lee June	See Remarks	58	$0	$1.97M	2019-09-23
Sanofi	10% Owner	8	$35.52M	$157.00M	2019-02-13
Semigran Marc	Chief Medical Officer	16	$0	$2.68M	2019-02-08
Lambing Joseph	See Remarks	24	$0	$1.26M	2019-02-08
STARR KEVIN P	Director, 10% Owner	17	$0	$71.43M	2018-03-07
LEVIN MARK J	10% Owner	1	$0	$0	2018-03-07
Third Rock Ventures III, L.P.	10% Owner	1	$0	$34.29M	2018-01-03
TEPPER ROBERT I	10% Owner	1	$0	$0	2017-12-06
TRV GP II, LLC	10% Owner	2	$0	$0	2017-09-28
Third Rock Ventures II, L.P.	10% Owner	8	$0	$9.14M	2017-09-28
Third Rock Ventures GP II, L.P.	10% Owner	3	$0	$25.86M	2017-09-26
TOPOL ERIC	Director	2	$0	$0	2017-06-14
Chan Steven	See Remarks	3	$0	$0	2017-01-18
HOMCY CHARLES J	Director	2	$0	$0	2016-11-29
Fox Jonathan C	Chief Medical Officer	2	$30.0K	$0	2016-04-29

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Waynick Denelle J	Chief Legal Officer	D To issuer deriv	2020-11-17	2020-11-19	80,000	—	$0	0	SEC↗
YARNO WENDY L	Director	D To issuer deriv	2020-11-17	2020-11-19	22,000	—	$0	0	SEC↗
YARNO WENDY L	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
YARNO WENDY L	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
YARNO WENDY L	Director	D To issuer deriv	2020-11-17	2020-11-19	6,600	—	$0	0	SEC↗
YARNO WENDY L	Director	D To issuer deriv	2020-11-17	2020-11-19	3,000	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	D To issuer deriv	2020-11-17	2020-11-19	149,517	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	D To issuer deriv	2020-11-17	2020-11-19	142,733	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	D To issuer deriv	2020-11-17	2020-11-19	236,500	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	D To issuer deriv	2020-11-17	2020-11-19	184,100	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	D To issuer deriv	2020-11-17	2020-11-19	303,500	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	D To issuer deriv	2020-11-17	2020-11-19	72,562	—	$0	0	SEC↗
CRANSTON MARY B	Director	D To issuer deriv	2020-11-17	2020-11-19	3,000	—	$0	0	SEC↗
CRANSTON MARY B	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
CRANSTON MARY B	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
CRANSTON MARY B	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
CRANSTON MARY B	Director	D To issuer deriv	2020-11-17	2020-11-19	6,600	—	$0	0	SEC↗
Popovits Kimberly J	Director	D To issuer deriv	2020-11-17	2020-11-19	3,000	—	$0	0	SEC↗
Popovits Kimberly J	Director	D To issuer deriv	2020-11-17	2020-11-19	22,000	—	$0	0	SEC↗
Popovits Kimberly J	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
Popovits Kimberly J	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
Popovits Kimberly J	Director	D To issuer deriv	2020-11-17	2020-11-19	6,600	—	$0	0	SEC↗
PERRY MARK L	Director	D To issuer deriv	2020-11-17	2020-11-19	3,000	—	$0	0	SEC↗
PERRY MARK L	Director	D To issuer deriv	2020-11-17	2020-11-19	21,800	—	$0	0	SEC↗
PERRY MARK L	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
PERRY MARK L	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
PERRY MARK L	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
PERRY MARK L	Director	D To issuer deriv	2020-11-17	2020-11-19	6,600	—	$0	0	SEC↗
Bauer Jake	Chief Business Officer	D To issuer deriv	2020-11-17	2020-11-19	45,193	—	$0	0	SEC↗
Bauer Jake	Chief Business Officer	D To issuer deriv	2020-11-17	2020-11-19	16,530	—	$0	0	SEC↗
Bauer Jake	Chief Business Officer	D To issuer deriv	2020-11-17	2020-11-19	8,748	—	$0	0	SEC↗
Bauer Jake	Chief Business Officer	D To issuer deriv	2020-11-17	2020-11-19	35,150	—	$0	0	SEC↗
Bauer Jake	Chief Business Officer	D To issuer deriv	2020-11-17	2020-11-19	57,400	—	$0	0	SEC↗
Bauer Jake	Chief Business Officer	D To issuer deriv	2020-11-17	2020-11-19	34,000	—	$0	0	SEC↗
Fairey William	EVP, Chief Commercial Office	D To issuer deriv	2020-11-17	2020-11-19	69,500	—	$0	0	SEC↗
Fairey William	EVP, Chief Commercial Office	D To issuer deriv	2020-11-17	2020-11-19	39,022	—	$0	0	SEC↗
AGARWAL SUNIL	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
AGARWAL SUNIL	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
AGARWAL SUNIL	Director	D To issuer deriv	2020-11-17	2020-11-19	3,000	—	$0	0	SEC↗
AGARWAL SUNIL	Director	D To issuer deriv	2020-11-17	2020-11-19	22,000	—	$0	0	SEC↗
AGARWAL SUNIL	Director	D To issuer deriv	2020-11-17	2020-11-19	6,600	—	$0	0	SEC↗
AGARWAL SUNIL	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
Harris Taylor C.	Chief Financial Officer	D To issuer deriv	2020-11-17	2020-11-19	100,000	—	$0	0	SEC↗
Harris Taylor C.	Chief Financial Officer	D To issuer deriv	2020-11-17	2020-11-19	46,060	—	$0	0	SEC↗
Harris Taylor C.	Chief Financial Officer	D To issuer deriv	2020-11-17	2020-11-19	49,400	—	$0	0	SEC↗
McDowell Robert Scott	Chief Scientific Officer	D To issuer deriv	2020-11-17	2020-11-19	57,400	—	$0	0	SEC↗
McDowell Robert Scott	Chief Scientific Officer	D To issuer deriv	2020-11-17	2020-11-19	46,000	—	$0	0	SEC↗
McDowell Robert Scott	Chief Scientific Officer	D To issuer deriv	2020-11-17	2020-11-19	38,818	—	$0	0	SEC↗
McDowell Robert Scott	Chief Scientific Officer	D To issuer deriv	2020-11-17	2020-11-19	20,000	—	$0	0	SEC↗
McDowell Robert Scott	Chief Scientific Officer	D To issuer deriv	2020-11-17	2020-11-19	79,850	—	$0	0	SEC↗
McDowell Robert Scott	Chief Scientific Officer	D To issuer deriv	2020-11-17	2020-11-19	27,211	—	$0	0	SEC↗
McDowell Robert Scott	Chief Scientific Officer	D To issuer deriv	2020-11-17	2020-11-19	36,735	—	$0	0	SEC↗
McDowell Robert Scott	Chief Scientific Officer	D To issuer deriv	2020-11-17	2020-11-19	40,816	—	$0	0	SEC↗
McDowell Robert Scott	Chief Scientific Officer	D To issuer deriv	2020-11-17	2020-11-19	87,074	—	$0	0	SEC↗
Meeker David P	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
Meeker David P	Director	D To issuer deriv	2020-11-17	2020-11-19	6,600	—	$0	0	SEC↗
Meeker David P	Director	D To issuer deriv	2020-11-17	2020-11-19	3,000	—	$0	0	SEC↗
Meeker David P	Director	D To issuer deriv	2020-11-17	2020-11-19	11,000	—	$0	0	SEC↗
Meeker David P	Director	D To issuer deriv	2020-11-17	2020-11-19	22,000	—	$0	0	SEC↗
Waynick Denelle J	Chief Legal Officer	U Tender	2020-11-17	2020-11-19	25,000	—	$0	0	SEC↗
YARNO WENDY L	Director	U Tender	2020-11-17	2020-11-19	5,508	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	U Tender	2020-11-17	2020-11-19	300,000	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	U Tender	2020-11-17	2020-11-19	129,407	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	U Tender	2020-11-17	2020-11-19	141,405	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	U Tender	2020-11-17	2020-11-19	53,087	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	U Tender	2020-11-17	2020-11-19	53,087	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	U Tender	2020-11-17	2020-11-19	53,087	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	U Tender	2020-11-17	2020-11-19	10,000	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	U Tender	2020-11-17	2020-11-19	7,000	—	$0	0	SEC↗
CRANSTON MARY B	Director	U Tender	2020-11-17	2020-11-19	4,100	—	$0	0	SEC↗
Popovits Kimberly J	Director	U Tender	2020-11-17	2020-11-19	4,100	—	$0	0	SEC↗
PERRY MARK L	Director	U Tender	2020-11-17	2020-11-19	29,508	—	$0	0	SEC↗
Bauer Jake	Chief Business Officer	U Tender	2020-11-17	2020-11-19	90,209	—	$0	0	SEC↗
Fairey William	EVP, Chief Commercial Office	U Tender	2020-11-17	2020-11-19	42,199	—	$0	0	SEC↗
AGARWAL SUNIL	Director	U Tender	2020-11-17	2020-11-19	4,100	—	$0	0	SEC↗
Harris Taylor C.	Chief Financial Officer	U Tender	2020-11-17	2020-11-19	42,559	—	$0	0	SEC↗
McDowell Robert Scott	Chief Scientific Officer	U Tender	2020-11-17	2020-11-19	36,616	—	$0	0	SEC↗
Meeker David P	Director	U Tender	2020-11-17	2020-11-19	4,100	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-07-02	2020-07-07	3,224	$94.22	$303.8K	19,122	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-07-02	2020-07-07	1,776	$93.55	$166.1K	22,346	SEC↗
Waynick Denelle J	General Counsel	A Award deriv	2020-07-01	2020-07-02	25,000	—	$0	25,000	SEC↗
Waynick Denelle J	General Counsel	A Award deriv	2020-07-01	2020-07-02	80,000	—	$0	80,000	SEC↗
CRANSTON MARY B	Director	S Sale	2020-06-30	2020-10-30	300	$97.25	$29.2K	23,629	SEC↗
CRANSTON MARY B	Director	M Exercise	2020-06-30	2020-10-30	21,629	$11.69	$252.8K	23,929	SEC↗
CRANSTON MARY B	Director	S Sale	2020-06-30	2020-10-30	21,329	$96.59	$2.06M	2,300	SEC↗
CRANSTON MARY B	Director	M Exercise deriv	2020-06-30	2020-07-01	21,629	—	$0	0	SEC↗
CRANSTON MARY B	Director	M Exercise	2020-06-30	2020-07-01	21,629	$11.69	$252.8K	21,629	SEC↗
CRANSTON MARY B	Director	S Sale	2020-06-30	2020-07-01	21,329	$96.59	$2.06M	0	SEC↗
CRANSTON MARY B	Director	S Sale	2020-06-30	2020-07-01	300	$97.25	$29.2K	21,329	SEC↗
CRANSTON MARY B	Director	S Sale	2020-06-29	2020-10-30	371	$98.68	$36.6K	2,300	SEC↗
CRANSTON MARY B	Director	M Exercise	2020-06-29	2020-10-30	371	$11.69	$4.3K	2,671	SEC↗
CRANSTON MARY B	Director	M Exercise deriv	2020-06-29	2020-07-01	371	—	$0	21,629	SEC↗
CRANSTON MARY B	Director	M Exercise	2020-06-29	2020-07-01	371	$11.69	$4.3K	371	SEC↗
CRANSTON MARY B	Director	S Sale	2020-06-29	2020-07-01	371	$98.68	$36.6K	0	SEC↗
YARNO WENDY L	Director	A Award deriv	2020-06-18	2020-06-22	1,800	—	$0	1,800	SEC↗
YARNO WENDY L	Director	A Award deriv	2020-06-18	2020-06-22	3,000	—	$0	3,000	SEC↗
Meeker David P	Director	A Award deriv	2020-06-18	2020-06-22	3,000	—	$0	3,000	SEC↗
Meeker David P	Director	A Award deriv	2020-06-18	2020-06-22	1,800	—	$0	1,800	SEC↗
Popovits Kimberly J	Director	A Award deriv	2020-06-18	2020-06-22	1,800	—	$0	1,800	SEC↗
Popovits Kimberly J	Director	A Award deriv	2020-06-18	2020-06-22	3,000	—	$0	3,000	SEC↗
AGARWAL SUNIL	Director	A Award deriv	2020-06-18	2020-06-22	3,000	—	$0	3,000	SEC↗
AGARWAL SUNIL	Director	A Award deriv	2020-06-18	2020-06-22	1,800	—	$0	1,800	SEC↗
CRANSTON MARY B	Director	A Award deriv	2020-06-18	2020-06-22	3,000	—	$0	3,000	SEC↗
CRANSTON MARY B	Director	A Award deriv	2020-06-18	2020-06-22	1,800	—	$0	1,800	SEC↗
PERRY MARK L	Director	A Award deriv	2020-06-18	2020-06-22	1,800	—	$0	1,800	SEC↗
PERRY MARK L	Director	A Award deriv	2020-06-18	2020-06-22	3,000	—	$0	3,000	SEC↗
CRANSTON MARY B	Director	M Exercise deriv	2020-06-13	2020-06-16	2,300	—	$0	0	SEC↗
YARNO WENDY L	Director	M Exercise deriv	2020-06-13	2020-06-16	2,300	—	$0	0	SEC↗
PERRY MARK L	Director	M Exercise deriv	2020-06-13	2020-06-16	2,300	—	$0	0	SEC↗
Meeker David P	Director	M Exercise deriv	2020-06-13	2020-06-16	2,300	—	$0	0	SEC↗
Popovits Kimberly J	Director	M Exercise deriv	2020-06-13	2020-06-16	2,300	—	$0	0	SEC↗
AGARWAL SUNIL	Director	M Exercise deriv	2020-06-13	2020-06-16	2,300	—	$0	0	SEC↗
AGARWAL SUNIL	Director	M Exercise deriv	2020-06-13	2020-06-23	2,300	—	$0	0	SEC↗
Meeker David P	Director	M Exercise deriv	2020-06-13	2020-06-23	2,300	—	$0	0	SEC↗
PERRY MARK L	Director	M Exercise deriv	2020-06-13	2020-06-23	2,300	—	$0	0	SEC↗
YARNO WENDY L	Director	M Exercise deriv	2020-06-13	2020-06-23	2,300	—	$0	0	SEC↗
Popovits Kimberly J	Director	M Exercise deriv	2020-06-13	2020-06-23	2,300	—	$0	0	SEC↗
CRANSTON MARY B	Director	M Exercise deriv	2020-06-13	2020-06-23	2,300	—	$0	0	SEC↗
CRANSTON MARY B	Director	M Exercise	2020-06-13	2020-06-16	2,300	—	$0	2,300	SEC↗
YARNO WENDY L	Director	M Exercise	2020-06-13	2020-06-16	2,300	—	$0	3,708	SEC↗
PERRY MARK L	Director	M Exercise	2020-06-13	2020-06-16	2,300	—	$0	27,708	SEC↗
Meeker David P	Director	M Exercise	2020-06-13	2020-06-16	2,300	—	$0	2,300	SEC↗
Popovits Kimberly J	Director	M Exercise	2020-06-13	2020-06-16	2,300	—	$0	2,300	SEC↗
AGARWAL SUNIL	Director	M Exercise	2020-06-13	2020-06-16	2,300	—	$0	2,300	SEC↗
AGARWAL SUNIL	Director	M Exercise	2020-06-13	2020-06-23	2,300	—	$0	2,300	SEC↗
Meeker David P	Director	M Exercise	2020-06-13	2020-06-23	2,300	—	$0	2,300	SEC↗
PERRY MARK L	Director	M Exercise	2020-06-13	2020-06-23	2,300	—	$0	27,708	SEC↗
YARNO WENDY L	Director	M Exercise	2020-06-13	2020-06-23	2,300	—	$0	3,708	SEC↗
Popovits Kimberly J	Director	M Exercise	2020-06-13	2020-06-23	2,300	—	$0	2,300	SEC↗
CRANSTON MARY B	Director	M Exercise	2020-06-13	2020-06-23	2,300	—	$0	2,300	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-06-02	2020-06-04	1,885	$103.77	$195.6K	24,441	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-06-02	2020-06-04	1,396	$102.78	$143.5K	26,326	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-06-02	2020-06-04	319	$104.64	$33.4K	24,122	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-06-02	2020-06-04	600	$100.60	$60.4K	28,522	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-06-02	2020-06-04	800	$101.72	$81.4K	27,722	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-05-18	2020-05-20	10,000	$125.00	$1.25M	29,122	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-05-11	2020-05-13	1,700	$100.51	$170.9K	61,822	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-05-11	2020-05-13	600	$98.69	$59.2K	63,522	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-05-11	2020-05-13	600	$103.33	$62.0K	39,122	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-05-11	2020-05-13	3,519	$102.56	$360.9K	39,722	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-05-11	2020-05-13	18,581	$101.90	$1.89M	43,241	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-05-04	2020-05-06	1,386	$56.93	$78.9K	77,736	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-05-04	2020-05-06	2,909	$59.10	$171.9K	74,427	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-05-04	2020-05-06	400	$58.05	$23.2K	77,336	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-05-04	2020-05-06	305	$60.15	$18.3K	74,122	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	M Exercise deriv	2020-04-30	2020-05-04	11,500	—	$0	121,626	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	M Exercise	2020-04-30	2020-05-04	11,500	$1.51	$17.4K	289,582	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	A Award	2020-04-30	2020-05-04	421	$50.41	$21.2K	278,082	SEC↗
Bauer Jake	Chief Business Officer	A Award	2020-04-30	2020-06-04	293	$50.41	$14.8K	57,784	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	G Gift	2020-04-20	2020-04-20	122,661	—	$0	0	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	G Gift	2020-04-17	2020-04-20	200,865	—	$0	122,661	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	G Gift	2020-04-17	2020-04-20	200,865	—	$0	277,661	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-04-16	2020-04-20	1,000	$55.00	$55.0K	76,796	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-04-08	2020-04-10	1,500	$50.00	$75.0K	77,796	SEC↗
Harris Taylor C.	Chief Financial Officer	S Sale	2020-04-06	2020-04-07	1,305	$46.99	$61.3K	7,438	SEC↗
Harris Taylor C.	Chief Financial Officer	M Exercise deriv	2020-04-04	2020-04-07	3,750	—	$0	7,500	SEC↗
Harris Taylor C.	Chief Financial Officer	M Exercise	2020-04-04	2020-04-07	3,750	—	$0	8,743	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-04-02	2020-04-06	300	$45.35	$13.6K	79,896	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-04-02	2020-04-06	600	$43.51	$26.1K	81,196	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-04-02	2020-04-06	1,000	$44.47	$44.5K	80,196	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-04-02	2020-04-06	600	$46.23	$27.7K	79,296	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-03-02	2020-03-04	22	$65.97	$1.5K	81,796	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-03-02	2020-03-04	2,070	$64.35	$133.2K	83,618	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-03-02	2020-03-04	1,800	$65.19	$117.3K	81,818	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-03-02	2020-03-04	1,108	$63.40	$70.2K	85,688	SEC↗
Harris Taylor C.	Chief Financial Officer	A Award deriv	2020-02-14	2020-02-19	14,871	—	$0	14,871	SEC↗
Harris Taylor C.	Chief Financial Officer	A Award deriv	2020-02-14	2020-02-19	46,060	—	$0	46,060	SEC↗
Fairey William	See Remarks	A Award deriv	2020-02-14	2020-02-19	12,598	—	$0	12,598	SEC↗
Fairey William	See Remarks	A Award deriv	2020-02-14	2020-02-19	39,022	—	$0	39,022	SEC↗
McDowell Robert Scott	Chief Scientific Officer	A Award deriv	2020-02-14	2020-02-19	12,533	—	$0	12,533	SEC↗
McDowell Robert Scott	Chief Scientific Officer	A Award deriv	2020-02-14	2020-02-19	38,818	—	$0	38,818	SEC↗
Bauer Jake	Chief Business Officer	A Award deriv	2020-02-14	2020-02-19	14,591	—	$0	14,591	SEC↗
Bauer Jake	Chief Business Officer	A Award deriv	2020-02-14	2020-02-19	45,193	—	$0	45,193	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	A Award deriv	2020-02-14	2020-02-19	46,083	—	$0	46,083	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	A Award deriv	2020-02-14	2020-02-19	142,733	—	$0	142,733	SEC↗
LADD CYNTHIA J	General Counsel	A Award deriv	2020-02-14	2020-02-19	31,079	—	$0	31,079	SEC↗
LADD CYNTHIA J	General Counsel	A Award deriv	2020-02-14	2020-02-19	10,034	—	$0	10,034	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-02-03	2020-02-05	1,000	$69.74	$69.7K	86,777	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-02-03	2020-02-05	4,000	$69.27	$277.1K	87,777	SEC↗
Fairey William	See Remarks	M Exercise deriv	2020-02-01	2020-02-03	8,125	—	$0	24,375	SEC↗
Fairey William	See Remarks	S Sale	2020-02-01	2020-02-03	2,899	$68.04	$197.2K	5,226	SEC↗
Fairey William	See Remarks	M Exercise	2020-02-01	2020-02-03	8,125	—	$0	8,125	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-01-14	2020-01-14	5,000	$75.39	$376.9K	91,777	SEC↗
Bauer Jake	Chief Business Officer	S Sale	2020-01-06	2020-01-07	2,466	$68.45	$168.8K	57,491	SEC↗
LADD CYNTHIA J	General Counsel	S Sale	2020-01-06	2020-01-07	1,849	$68.45	$126.6K	2,851	SEC↗
McDowell Robert Scott	Chief Scientific Officer	S Sale	2020-01-06	2020-01-07	2,650	$68.45	$181.4K	5,383	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-01-06	2020-01-07	12,687	$68.45	$868.4K	96,777	SEC↗
Harris Taylor C.	Chief Financial Officer	S Sale	2020-01-06	2020-01-07	1,683	$68.45	$115.2K	4,993	SEC↗
Bauer Jake	Chief Business Officer	M Exercise deriv	2020-01-03	2020-01-07	10,000	—	$0	6,326	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-01-03	2020-01-03	2,084	$72.27	$150.6K	109,464	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-01-03	2020-01-03	2,616	$71.59	$187.3K	111,548	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2020-01-03	2020-01-03	300	$70.35	$21.1K	114,164	SEC↗
Bauer Jake	Chief Business Officer	M Exercise	2020-01-03	2020-01-07	10,000	$1.51	$15.1K	59,957	SEC↗
Bauer Jake	Chief Business Officer	M Exercise deriv	2020-01-01	2020-01-03	4,950	—	$0	14,850	SEC↗
Bauer Jake	Chief Business Officer	M Exercise deriv	2020-01-01	2020-01-03	1,425	—	$0	2,850	SEC↗
Harris Taylor C.	Chief Financial Officer	M Exercise deriv	2020-01-01	2020-01-03	4,250	—	$0	12,750	SEC↗
LADD CYNTHIA J	General Counsel	M Exercise deriv	2020-01-01	2020-01-03	4,700	—	$0	14,100	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	M Exercise deriv	2020-01-01	2020-01-03	7,650	—	$0	15,300	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	M Exercise deriv	2020-01-01	2020-01-03	20,300	—	$0	60,900	SEC↗
McDowell Robert Scott	Chief Scientific Officer	M Exercise deriv	2020-01-01	2020-01-03	1,925	—	$0	3,850	SEC↗
McDowell Robert Scott	Chief Scientific Officer	M Exercise deriv	2020-01-01	2020-01-03	4,950	—	$0	14,850	SEC↗
Bauer Jake	Chief Business Officer	M Exercise	2020-01-01	2020-01-03	6,375	—	$0	49,957	SEC↗
Harris Taylor C.	Chief Financial Officer	M Exercise	2020-01-01	2020-01-03	4,250	—	$0	6,676	SEC↗
LADD CYNTHIA J	General Counsel	M Exercise	2020-01-01	2020-01-03	4,700	—	$0	4,700	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	M Exercise	2020-01-01	2020-01-03	27,950	—	$0	114,464	SEC↗
McDowell Robert Scott	Chief Scientific Officer	M Exercise	2020-01-01	2020-01-03	6,875	—	$0	8,033	SEC↗
Bauer Jake	Chief Business Officer	M Exercise deriv	2019-12-20	2019-12-23	7,500	—	$0	0	SEC↗
Bauer Jake	Chief Business Officer	M Exercise deriv	2019-12-20	2019-12-23	10,000	—	$0	8,748	SEC↗
Bauer Jake	Chief Business Officer	M Exercise	2019-12-20	2019-12-23	7,500	$13.90	$104.3K	62,498	SEC↗
Bauer Jake	Chief Business Officer	M Exercise	2019-12-20	2019-12-23	10,000	$9.08	$90.8K	54,998	SEC↗
Bauer Jake	Chief Business Officer	S Sale	2019-12-20	2019-12-23	18,916	$70.07	$1.33M	43,582	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-12-02	2019-12-04	4,350	$65.14	$283.4K	86,514	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-12-02	2019-12-04	650	$64.24	$41.8K	90,864	SEC↗
Bauer Jake	Chief Business Officer	S Sale	2019-11-29	2019-12-02	7,336	$65.52	$480.7K	45,798	SEC↗
Bauer Jake	Chief Business Officer	S Sale	2019-11-29	2019-12-02	800	$66.32	$53.1K	44,998	SEC↗
Bauer Jake	Chief Business Officer	S Sale	2019-11-27	2019-12-02	13,096	$65.13	$852.9K	53,134	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-11-04	2019-11-06	5,000	$59.07	$295.4K	91,514	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	A Award	2019-10-31	2019-11-06	44	$40.07	$1.8K	96,514	SEC↗
Bauer Jake	Chief Business Officer	A Award	2019-10-31	2019-11-08	162	$40.07	$6.5K	66,230	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-10-03	2019-10-04	1,000	$55.00	$55.0K	96,470	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-10-02	2019-10-04	700	$51.33	$35.9K	100,770	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-10-02	2019-10-04	2,542	$52.29	$132.9K	98,228	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-10-02	2019-10-04	758	$53.10	$40.2K	97,470	SEC↗
Lee June	EVP, Chief Development Offic	M Exercise deriv	2019-09-23	2019-09-24	12,625	—	$0	115,617	SEC↗
Lee June	EVP, Chief Development Offic	S Sale	2019-09-23	2019-09-24	800	$59.95	$48.0K	8,314	SEC↗
Lee June	EVP, Chief Development Offic	S Sale	2019-09-23	2019-09-24	4,161	$58.97	$245.4K	9,114	SEC↗
Lee June	EVP, Chief Development Offic	S Sale	2019-09-23	2019-09-24	3,929	$58.33	$229.2K	13,275	SEC↗
Lee June	EVP, Chief Development Offic	M Exercise	2019-09-23	2019-09-24	12,625	$11.95	$150.9K	17,204	SEC↗
Lee June	EVP, Chief Development Offic	S Sale	2019-09-23	2019-09-24	4,161	$61.09	$254.2K	4,153	SEC↗
Bauer Jake	Chief Business Officer	M Exercise deriv	2019-09-20	2019-09-24	9,700	—	$0	40,150	SEC↗
Bauer Jake	Chief Business Officer	M Exercise deriv	2019-09-20	2019-09-24	10,000	—	$0	18,748	SEC↗
Bauer Jake	Chief Business Officer	M Exercise	2019-09-20	2019-09-24	9,700	$12.25	$118.8K	85,768	SEC↗
Bauer Jake	Chief Business Officer	M Exercise	2019-09-20	2019-09-24	10,000	$9.08	$90.8K	76,068	SEC↗
Bauer Jake	Chief Business Officer	S Sale	2019-09-20	2019-09-24	19,700	$60.09	$1.18M	66,068	SEC↗
Lee June	EVP, Chief Development Offic	M Exercise deriv	2019-09-19	2019-09-20	5,435	—	$0	128,242	SEC↗
Lee June	EVP, Chief Development Offic	M Exercise	2019-09-19	2019-09-20	5,435	$11.95	$64.9K	10,014	SEC↗
Lee June	EVP, Chief Development Offic	S Sale	2019-09-19	2019-09-20	5,435	$57.08	$310.2K	4,579	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-09-11	2019-09-12	1,000	$55.00	$55.0K	101,470	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-09-03	2019-09-05	1,100	$54.09	$59.5K	102,470	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-09-03	2019-09-05	1,900	$50.70	$96.3K	104,570	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-09-03	2019-09-05	1,000	$52.75	$52.8K	103,570	SEC↗
Lee June	EVP, Chief Development Offic	M Exercise deriv	2019-08-09	2019-08-12	4,565	—	$0	133,677	SEC↗
Lee June	EVP, Chief Development Offic	S Sale	2019-08-09	2019-08-12	4,565	$57.00	$260.2K	4,579	SEC↗
Lee June	EVP, Chief Development Offic	M Exercise	2019-08-09	2019-08-12	4,565	$11.95	$54.6K	9,144	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-08-08	2019-08-09	1,000	$55.09	$55.1K	106,470	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-08-02	2019-08-05	200	$53.82	$10.8K	107,470	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-08-02	2019-08-05	3,800	$53.20	$202.2K	107,670	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-07-22	2019-07-23	1,000	$55.00	$55.0K	111,470	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-07-05	2019-07-08	1,550	$49.13	$76.2K	114,920	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-07-05	2019-07-08	2,450	$50.10	$122.7K	112,470	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	G Gift	2019-06-18	2019-07-08	39,000	—	$0	116,470	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	G Gift	2019-06-18	2019-07-08	39,000	—	$0	49,473	SEC↗
Popovits Kimberly J	Director	A Award deriv	2019-06-13	2019-06-17	2,300	—	$0	2,300	SEC↗
Popovits Kimberly J	Director	A Award deriv	2019-06-13	2019-06-17	6,600	—	$0	6,600	SEC↗
AGARWAL SUNIL	Director	A Award deriv	2019-06-13	2019-06-17	2,300	—	$0	2,300	SEC↗
AGARWAL SUNIL	Director	A Award deriv	2019-06-13	2019-06-17	6,600	—	$0	6,600	SEC↗
Meeker David P	Director	A Award deriv	2019-06-13	2019-06-17	6,600	—	$0	6,600	SEC↗
Meeker David P	Director	A Award deriv	2019-06-13	2019-06-17	2,300	—	$0	2,300	SEC↗
CRANSTON MARY B	Director	A Award deriv	2019-06-13	2019-06-17	2,300	—	$0	2,300	SEC↗
CRANSTON MARY B	Director	A Award deriv	2019-06-13	2019-06-17	6,600	—	$0	6,600	SEC↗
YARNO WENDY L	Director	A Award deriv	2019-06-13	2019-06-17	2,300	—	$0	2,300	SEC↗
YARNO WENDY L	Director	A Award deriv	2019-06-13	2019-06-17	6,600	—	$0	6,600	SEC↗
PERRY MARK L	Director	A Award deriv	2019-06-13	2019-06-17	6,600	—	$0	6,600	SEC↗
PERRY MARK L	Director	A Award deriv	2019-06-13	2019-06-17	2,300	—	$0	2,300	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	A Award	2019-04-30	2019-06-03	503	$40.78	$20.5K	77,470	SEC↗
Bauer Jake	Chief Business Officer	A Award	2019-04-30	2019-06-03	313	$40.78	$12.8K	66,068	SEC↗
Lee June	EVP, Chief Development Offic	A Award	2019-04-30	2019-06-03	401	$40.78	$16.4K	4,579	SEC↗
Harris Taylor C.	Chief Financial Officer	M Exercise deriv	2019-04-05	2019-04-09	3,750	—	$0	11,250	SEC↗
Harris Taylor C.	Chief Financial Officer	M Exercise	2019-04-05	2019-04-09	3,750	—	$0	3,750	SEC↗
Harris Taylor C.	Chief Financial Officer	S Sale	2019-04-05	2019-04-09	1,324	$53.30	$70.6K	2,426	SEC↗
Lee June	See Remarks	M Exercise deriv	2019-03-14	2019-03-18	1,758	—	$0	138,242	SEC↗
Lee June	See Remarks	M Exercise	2019-03-14	2019-03-18	1,758	$11.95	$21.0K	4,178	SEC↗
Lee June	EVP, Chief Development Offic	M Exercise deriv	2019-02-25	2019-10-29	3,000	—	$0	3,250	SEC↗
Lee June	EVP, Chief Development Offic	M Exercise	2019-02-25	2019-10-29	3,000	$11.95	$35.9K	22,157	SEC↗
Sanofi	10% Owner	S Sale	2019-02-13	2019-02-15	4,168,899	$37.66	$157.00M	0	SEC↗
Bauer Jake	Chief Business Officer	A Award deriv	2019-02-08	2019-02-12	19,800	—	$0	19,800	SEC↗
Bauer Jake	Chief Business Officer	A Award deriv	2019-02-08	2019-02-12	57,400	—	$0	57,400	SEC↗
Harris Taylor C.	Chief Financial Officer	A Award deriv	2019-02-08	2019-02-12	17,000	—	$0	17,000	SEC↗
Harris Taylor C.	Chief Financial Officer	A Award deriv	2019-02-08	2019-02-12	49,400	—	$0	49,400	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	A Award deriv	2019-02-08	2019-02-12	81,200	—	$0	81,200	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	A Award deriv	2019-02-08	2019-02-12	236,500	—	$0	236,500	SEC↗
McDowell Robert Scott	Chief Scientific Officer	A Award deriv	2019-02-08	2019-02-12	19,800	—	$0	19,800	SEC↗
McDowell Robert Scott	Chief Scientific Officer	A Award deriv	2019-02-08	2019-02-12	57,400	—	$0	57,400	SEC↗
Lambing Joseph	See Remarks	A Award deriv	2019-02-08	2019-02-12	24,900	—	$0	24,900	SEC↗
Lambing Joseph	See Remarks	A Award deriv	2019-02-08	2019-02-12	8,500	—	$0	8,500	SEC↗
Lee June	See Remarks	A Award deriv	2019-02-08	2019-02-12	22,600	—	$0	22,600	SEC↗
Lee June	See Remarks	A Award deriv	2019-02-08	2019-02-12	65,000	—	$0	65,000	SEC↗
Semigran Marc	Chief Medical Officer	A Award deriv	2019-02-08	2019-02-12	8,500	—	$0	8,500	SEC↗
Semigran Marc	Chief Medical Officer	A Award deriv	2019-02-08	2019-02-12	24,900	—	$0	24,900	SEC↗
LADD CYNTHIA J	General Counsel	A Award deriv	2019-02-08	2019-02-12	18,800	—	$0	18,800	SEC↗
LADD CYNTHIA J	General Counsel	A Award deriv	2019-02-08	2019-02-12	55,100	—	$0	55,100	SEC↗
Fairey William	See Remarks	A Award deriv	2019-02-01	2019-02-05	69,500	—	$0	69,500	SEC↗
Fairey William	See Remarks	A Award deriv	2019-02-01	2019-02-05	32,500	—	$0	32,500	SEC↗
McDowell Robert Scott	Chief Scientific Officer	F Tax w/h	2019-01-07	2019-01-09	767	$44.15	$33.9K	1,158	SEC↗
Lambing Joseph	See Remarks	F Tax w/h	2019-01-07	2019-01-09	351	$43.99	$15.4K	94,740	SEC↗
Bauer Jake	Chief Business Officer	F Tax w/h	2019-01-07	2019-01-09	570	$42.98	$24.5K	60,755	SEC↗
Semigran Marc	Chief Medical Officer	F Tax w/h	2019-01-07	2019-01-09	517	$44.26	$22.9K	1,110	SEC↗
Lee June	See Remarks	F Tax w/h	2019-01-07	2019-01-09	1,100	$44.06	$48.5K	2,420	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	S Sale	2019-01-07	2019-01-11	2,770	$44.11	$122.2K	76,967	SEC↗
GIANAKAKOS ANASTASIOS	President and CEO	P Buy	2019-01-04	2019-01-08	1,600	$39.87	$63.8K	88,473	SEC↗